Extraordinary times demand extraordinary leadership. To help us shape our future strategy and champion our mission, BelCham is excited to welcome these two incredible leaders to the Board:
Annastasiah Mudiwa Mhaka, PhD is an experienced lifesciences executive, investment professional, and entrepreneur with a passion for global health. Dr. Mhaka has co-founded the Alliance for Artificial Intelligence in (AAIH). In addition to her proven track record of over 50+ cross-industry deals in both the private and public sector, Dr. Mhaka has worked for a leading management consultant firm, and co-founded four companies within the drug development and nanotechnology sectors. Dr. Mhaka received her PhD in Cellular and Molecular Medicine from Johns Hopkins Medicine where she developed a clinical phase oncology drug and obtained her Bachelor of Science in Chemistry from the University of Pittsburgh.
Tom Vanham is CEO of LRM NV, a regional investment firm in Belgium with 250+ portfolio companies and an average annual deal flow of approx. $100M. He holds a Master degree in Law (KU Leuven) and attended Antwerp Management School, IMD and Wharton. He started his career in the insurance industry at AIG, both in Brussels as at their HQ in NYC. After that, he joined Marsh, the global broker firm, before moving to Accenture for which he managed strategic projects and assisted clients with their expansion into new European markets. In the last 10 years he assumed senior management roles at AXA, first in Belgium, afterwards at group level in Paris, running a business unit across Central and Eastern Europe. He then joined Generali in Belgium where he became CEO in 2017 managing app. 8 billion dollar in assets and 430 employees.